Frontlight ResearchEarly access
Trial site
Cleveland Clinic Taussig Cancer Institute
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Multiple myeloma3 trials
- Sarcoma3 trials
- Acute myeloid leukaemia2 trials
- Melanoma2 trials
- Thyroid cancer2 trials
- Amyloidosis1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- and 4 more
- Phase
- Phase 27 trials
- Phase 14 trials
- Phase 34 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting4 trials
- Completed4 trials
- Terminated2 trials
- Lead sponsor
- M.D. Anderson Cancer Center2 trials
- Seagen Inc.2 trials
- Gilead Sciences1 trial
- Hoffmann-La Roche1 trial
- Immatics US, Inc.1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Sarcoma2 recruiting
- Acute myeloid leukaemia1 recruiting
- Amyloidosis1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Heart failure1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Terminated
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Completed
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 19 Nov 2026